Colon cancer screening programs prevent cancer.
Flynn, Duncan J, and Joseph D Feuerstein. 2024. “Colon Cancer Screening Programs Prevent Cancer.”. World Journal of Gastroenterology 30 (42): 4566-68.
Search
Search results
4256 results found
Communicating Information Regarding IBD Remission to Patients: Evidence From a Survey of Adult Patients in the United States.
Wood, Dallas W, Katherine Treiman, Aileen Rivell, Welmoed K van Deen, Hilary Heyison, Mark C Mattar, Sydney Power, et al. 2025. “Communicating Information Regarding IBD Remission to Patients: Evidence From a Survey of Adult Patients in the United States.”. Inflammatory Bowel Diseases 31 (6): 1605-15.
B and T cells: (Still) the dominant orchestrators in autoimmune hepatitis.
Longhi, Maria Serena, Lina Zhang, Giorgina Mieli-Vergani, and Diego Vergani. 2024. “B and T Cells: (Still) the Dominant Orchestrators in Autoimmune Hepatitis.”. Autoimmunity Reviews 23 (7-8): 103591.
Perceptions regarding the impact of gender on training and career advancement among gastroenterologists in India and other South Asian countries.
Mishra, Shubhra, Anuraag Jena, Loren Galler Rabinowitz, Lubna Kamani, Mukesh Sharma Paudel, Madhumita Premkumar, Usha Dutta, Manu Tandan, Rakesh Kochhar, and Vishal Sharma. 2024. “Perceptions Regarding the Impact of Gender on Training and Career Advancement Among Gastroenterologists in India and Other South Asian Countries.”. Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology.
Insurance Companies' Poor Adherence to Guidelines for Moderate-to-Severe Ulcerative Colitis/Crohn's Disease Management.
Anderson, Kelsey L, Rajsavi Anand, and Joseph D Feuerstein. 2024. “Insurance Companies’ Poor Adherence to Guidelines for Moderate-to-Severe Ulcerative Colitis/Crohn’s Disease Management.”. The American Journal of Gastroenterology.
Anti-infliximab antibodies and low infliximab levels correlate with drug discontinuation in pediatric inflammatory bowel disease.
Zitomersky, Naamah, Lisa Chi, Enju Liu, Kurtis R Bray, Konstantinos Papamichael, Adam S Cheifetz, Scott B Snapper, Athos Bousvaros, and Jocelyn A Silvester. 2024. “Anti-Infliximab Antibodies and Low Infliximab Levels Correlate With Drug Discontinuation in Pediatric Inflammatory Bowel Disease.”. Journal of Pediatric Gastroenterology and Nutrition 78 (2): 261-71.
Disparities in Rates of Multitarget Stool DNA Test Completion for Colorectal Cancer Screening.
Dong, Jeffrey, Hyder Said, Samuel J Miller, Hannah K Systrom, and Joseph D Feuerstein. 2024. “Disparities in Rates of Multitarget Stool DNA Test Completion for Colorectal Cancer Screening.”. Journal of Clinical Gastroenterology 58 (8): 805-9.
Parental Leave and Return-to-Work Policies: A Practical Model for Implementation in Gastroenterology.
Feld, Lauren D, Amy S Oxentenko, Dawn Sears, Aline Charabaty, Loren G Rabinowitz, and Julie K Silver. 2023. “Parental Leave and Return-to-Work Policies: A Practical Model for Implementation in Gastroenterology.”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 21 (11): 2709-15.
Development of Antibodies to Ustekinumab Is Associated with Loss of Response in Patients with Inflammatory Bowel Disease.
Roblin, Xavier, Gérard Duru, Konstantinos Papamichael, Adam S Cheifetz, Sandy Kwiatek, Anne-Emmanuelle Berger, Mathilde Barrau, Louis Waeckel, Stéphane Nancey, and Stephane Paul. 2023. “Development of Antibodies to Ustekinumab Is Associated With Loss of Response in Patients With Inflammatory Bowel Disease.”. Journal of Clinical Medicine 12 (10).
Pancreatic Cancer Screening for At-Risk Individuals (Pancreas Scan Study): Yield, Harms, and Outcomes From a Prospective Multicenter Study.
Shah, Ishani, Andy Silva-Santisteban, Katharine A Germansky, Arvind Trindade, Kara L Raphael, Vladimir Kushnir, Rishi Pawa, et al. 2023. “Pancreatic Cancer Screening for At-Risk Individuals (Pancreas Scan Study): Yield, Harms, and Outcomes From a Prospective Multicenter Study.”. The American Journal of Gastroenterology 118 (9): 1664-70.